×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Esperion to Report First Quarter 2024 Financial Results on May 7
Yahoo Finance
ANN ARBOR, Mich., April 23, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report first quarter 2024 financial...
4 days ago
Esperion Therapeutics, Inc. Rings the Opening Bell
Nasdaq
About This Event Esperion (Nasdaq: ESPR), a pharmaceutical company who recently announced the U.S. FDA approval of expanded indications for...
4 weeks ago
Esperion Therapeutics Gets CHMP Positive Opinion for Cholesterol Medications
MarketWatch
By Chris Wack Esperion Therapeutics, along with partner Daiichi Sankyo Europe, said the European Medicines Agency's Committee for Medicinal...
1 month ago
Daiichi Sankyo to Pay Esperion $125M in Settlement of Milestone Payment Lawsuit
BioSpace
Wednesday's settlement resolves a legal dispute between Daiichi Sankyo Europe and Esperion Therapeutics regarding milestone payments under...
3 months ago
FDA Approves Updated LDL-C Lowering Indication for Esperion's Nexletol, Nexlizet Tablets
Drug Topics
FDA Approves Updated LDL-C Lowering Indication for Esperion's Nexletol, Nexlizet Tablets ... The federal agency also removed the maximally...
4 months ago
Esperion snags US label expansion for cardiovascular disease drugs
Pharmaceutical Technology
Esperion Therapeutics' Nexletol and Nexlizet are now available for patients with cardiovascular risk in the US.
1 month ago
Nexletol partners Esperion and Daiichi Sankyo patch up milestone dispute with $125M settlement
Fierce Pharma
After a dispute over milestone payments derailed a 2019 heart med collaboration, Daiichi Sankyo and Esperion Therapeutics have mended fences...
3 months ago
Esperion Therapeutics Shares Tumble Premarket on Stock Offering
MarketWatch
By Colin Kellaher Shares of Esperion Therapeutics slid 25% in premarket trading Friday after the pharmaceutical company said it was raising...
3 months ago
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL ...
Yahoo Finance
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse...
3 weeks ago
Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024
Yahoo Finance
ANN ARBOR, Mich., April 01, 2024 (GLOBE NEWSWIRE) -- Esperion (Nasdaq: ESPR) today announced that Sheldon Koenig, President and CEO,...
4 weeks ago